Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GO-FURTHER: Golimumab IV + MTX in Active RA
NCT00973479Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2009
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 3 trial of golimumab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Sep 2009; status: completed.
02
Drugs
golimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00973479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973479.